Trends in Cardiovascular Medicine
Volume 15, Issue 2 , Pages 69-75 , February 2005

The Reperfusion Injury Salvage Kinase Pathway: A Common Target for Both Ischemic Preconditioning and Postconditioning

  • Derek J. Hausenloy
    • ,
  • Andrew Tsang
    • ,
  • Derek M. Yellon

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Derek M. Yellon, PhD, DSc, Hon FRCP, The Hatter Institute and Centre for Cardiology, University College London Hospital, Grafton Way, WC1E 6DB London, UK. Tel.: (+44) 207-380-9776; fax: (+44) 207-388-5095

References 

  1. Argaud L, Gateau-Roesch J, Loufouat D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;18:194–197
  2. Baines CP, Song CX, Zheng YT, et al. Protein kinase C-ɛ interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res. 2003;92:873–880
  3. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCɛ and MAPK form signaling modules in the murine heart: Enhanced mitochondrial PKCɛ-MAPK interactions and differential MAPK activation in PKCɛ-induced cardioprotection. Circ Res. 2002;90:390–397
  4. Behrends M, Schulz R, Post H, et al. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. Am J Physiol. 2000;279:H1111–H1119
  5. Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol. 2003;41:508–515
  6. Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol. 2003;35:185–193
  7. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword?. J Clin Invest. 1985;76:1713–1719
  8. Brookes PS, Salinas EP, Darley-Usmar K, et al. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem. 2000;275:20474–20479
  9. Davidson S, Hausenloy DJ, Duchen M, et al. Insulin inhibits opening of the mitochondrial permeability transition pore via the reperfusion injury salvage kinase (RISK) pathway. Circulation. 2004;100:131
  10. Fath-Ordoubadi F, Beatt K. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview or randomized placebo-controlled trials. Circulation. 1997;96:1152–1156
  11. Freude B, Masters TN, Robicsek F, et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol. 2000;32:197–208
  12. Fryer RM, Pratt PF, Hsu AK, et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther. 2001;296:642–649
  13. Fujio Y, Nguyen T, Wencker D. Akt promotes survival of cardiomyocytes against ischemia–reperfusion injury in mouse heart. Circulation. 2000;101:660–667
  14. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:1621–1628
  15. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94:960–966
  16. Hausenloy DJ, Maddock HL, Baxter GF, et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res. 2002;55:534–543
  17. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003;35:339–341
  18. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61:448–460
  19. Hausenloy DJ, Yellon DM, Mani-Babu S, et al. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol. 2004;287:H841–H849
  20. Hausenloy DJ, Tsang A, Mocanu MM, et al. Ischemic preconditioning protects by activating pro-survival kinases at reperfusion. Am J Physiol. 2005;288:H971–H976
  21. Heusch G. Postconditioning: old wine in a new bottle?. J Am Coll Cardiol. 2004;44:1111–1112
  22. Jonassen AK, Sack MN, Mjos OD, et al. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191–1198
  23. Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113:1535–1549
  24. Kin H, Lofye MT, Amerson BS, et al. Cardioprotection by “postconditioning” is mediated by increased retention of endogenous intravascular adenosine and activation of A2A receptors during reperfusion. Circulation. 2004;100:803
  25. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74–85
  26. Krieg T, Qin Q, McIntosh EC, et al. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol. 2002;283:H2322–H2330
  27. Krieg T, Cui L, Qin Q, et al. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol. 2004;36:435–443
  28. Krieg T, Qin Q, Philipp S, et al. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol. 2004;287:H2606–H2611
  29. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437–446
  30. Miao W, Luo Z, Kitsis RN, et al. Intracoronary adenovirus-mediated Akt gene transfer in hearts limits infarct size following ischemia–reperfusion injury. J Mol Cell Cardiol. 2000;32:2397–2402
  31. Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol. 2002;34:661–668
  32. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  33. Nikolaidis LA, Mankad S, Sokos GG, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004;109:962–965
  34. Okamoto F, Allen BS, Buckberg GD, et al. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg. 1986;92:613–620
  35. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol. 2004;286:H468–H476
  36. Philipp S, Downey JM, Cohen MV. Postconditioning must be initiated in less than 1 minute following reperfusion and is dependent on adenosine receptors and PI3-kinase. Circulation. 2004;100:804
  37. Samavati L, Monick MM, Sanlioglu S, et al. Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol. 2002;283:C273–C281
  38. Schulman D, Latchman DS, Yellon DM. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol. 2002;283:H1481–H1488
  39. Solenkova N, Cohen MV, Downey JM. PI3 kinase supports the preconditioned heart through a critical convalescent period. JMCC. 2005;(submitted)
  40. Tong H, Chen W, Steenbergen C, et al. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res. 2000;87:309–315
  41. Tong H, Imahashi K, Steenbergen C, et al. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res. 2002;90:377–379
  42. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230–232
  43. Tsuruta F, Masuyama N, Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem. 2002;277:14040–14047
  44. Yang XM, Krieg T, Cui L, et al. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol. 2004;36:411–421
  45. Yang XM, Proctor JB, Cui L, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004;44:1103–1110
  46. Yellon DM, Baxter GF. Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury?. Trends Cardiovasc Med. 1999;9:245–249
  47. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol. 2003;285:H579–H588

PII: S1050-1738(05)00025-3

doi: 10.1016/j.tcm.2005.03.001

Trends in Cardiovascular Medicine
Volume 15, Issue 2 , Pages 69-75 , February 2005

Article Tools

* Image Usage & Resolution